Marfan's syndrome and the heart
- PMID: 17376944
- PMCID: PMC2083669
- DOI: 10.1136/adc.2006.097469
Marfan's syndrome and the heart
Abstract
In recent years, there have been many advances in the treatment of cardiac disease in children with Marfan's syndrome. Early diagnosis, meticulous echocardiographic follow-up and multidisciplinary assessment are essential. Medical treatment with beta-blockers is probably helpful in most children with aortic root dilatation. Research on TGFbeta signalling and the potential treatment role of TGFbeta antagonists may lead to exciting new treatments, but the results of clinical trials are awaited. In managing the cardiovascular complications of Marfan's syndrome, the paediatrician has to walk a difficult path. On the one hand, restrictive lifestyle advice and drugs may need to be prescribed, often in the context of a family history of major surgery or even sudden death. On the other hand, it is essential to encourage the often asymptomatic child to develop and mature as normally as possible.
Conflict of interest statement
Competing interests: AGS is a Medical Advisor to the Marfan Association UK.
References
-
- Marfan A B. Un cas de deformation congenitale des quatre membres, plus prononce aux extremetes, characterise par l'allongement des os avec un certain degre d'amincissement. Bull Mem Soc Med Hop (Paris) 189613220–226.
-
- Salle V. Ueber einen fall von angeborner abnormen Grosse der Extremitaten mit einen an Akronemegalia erinerden Symptomenkomplex. Jahrb Kinderkeilk 191275540–550.
-
- Pyeritz R E. The Marfan syndrome. Annu Rev Med 200051481–510. - PubMed
-
- Dietz H C, Pyeritz R E, Hall B D.et al The Marfan syndrome locus: confirmation of assignment to chromosome 15 and identification of tightly linked markers at 15q15–q21.3. Genomics 19919355–361. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical